Accretion Pharmaceuticals IPO

NSELot: 1200

LISTEDSME
Issue Price101
Listing-
Current69.6
Price Band
96 - ₹101
Lot Size
1,200
Issue Size
₹29.75 Cr
GMP
0
Subscription
1.12x

IPO Schedule

1
Open
14 May
2
Close
16 May
3
Allotment
-
4
Listing
21 May

About Accretion Pharmaceuticals

Accretion Pharmaceuticals is an SME focused on manufacturing and marketing pharmaceutical formulations. They operate primarily within the domestic market, supplying a range of therapeutic products.

Subscription Status

QIB
0.00x
NII
0.51x
Retail
1.86x
CategoryDay 3Day 2Day 1
QIB12.14x0.75x0.00x
NII4.28x0.92x0.51x
Retail10.54x4.01x1.86x
Total7.67x2.37x1.12x

Risk Factors

SME segment listing carries inherent risks associated with smaller companies, including limited financial resources and operational scale.
Pharmaceutical industry is highly regulated and competitive, requiring continuous investment in R&D and marketing.
Dependence on domestic market exposes the company to local economic conditions and regulatory changes.